Sep 2026
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of HZBio1 in Chinese Healthy Subjects: A Randomized Phase 1a Study.
Hong-Zhong Liu, Xin Zheng, Chuan-Qing Yang et al.
· Advances in Therapy · 0 citations